COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries.
作者信息
Mazur Anne, Benitez Stefanie, Chuffart-Finsterwald Stéphanie, La Rotta Rafael, Hampton Lee M
机构信息
The World Health Organization (WHO), Avenue Appia 20, 1202 Geneva, Switzerland.
Sigma Legal, Rue de Berne 10, 1201 Geneva, Switzerland.
出版信息
Vaccine. 2021 Dec 3;39(49):7128-7130. doi: 10.1016/j.vaccine.2021.10.047. Epub 2021 Oct 28.
Abstract
摘要
相似文献
1
COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries.针对92个低收入和中等收入国家新冠疫苗接种损伤的COVAX无过错补偿计划。
Vaccine. 2021 Dec 3;39(49):7128-7130. doi: 10.1016/j.vaccine.2021.10.047. Epub 2021 Oct 28.
2
No-fault compensation schemes for COVID-19 vaccine injury: a mixed bag for claimants and citizens.新冠疫苗伤害的无过错补偿计划：对索赔者和公民来说好坏参半。
J Med Ethics. 2025 Jan 23;51(2):115-120. doi: 10.1136/jme-2024-109900.
3
International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.国际合作确保公平获取 COVID-19 疫苗：ACT-Accelerator 和 COVAX 设施。
Milbank Q. 2021 Jun;99(2):426-449. doi: 10.1111/1468-0009.12503. Epub 2021 Mar 2.
4
Comparative analysis of fourteen COVID-19 vaccine injury compensation systems and claim approval rates.14种新冠疫苗伤害赔偿系统及索赔批准率的比较分析
Vaccine. 2025 Apr 11;52:126830. doi: 10.1016/j.vaccine.2025.126830. Epub 2025 Mar 3.
5
COVAX and equitable access to COVID-19 vaccines.新冠疫苗实施计划与公平获取疫苗。
Bull World Health Organ. 2022 May 1;100(5):315-328. doi: 10.2471/BLT.21.287516. Epub 2022 Mar 25.
6
No-Fault Compensation for Vaccine Injury - The Other Side of Equitable Access to Covid-19 Vaccines.疫苗伤害的无过错补偿——公平获取新冠疫苗的另一面
N Engl J Med. 2020 Dec 3;383(23):e125. doi: 10.1056/NEJMp2030600. Epub 2020 Oct 28.
7
Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines.专家观点：关于 COVAX 以及公平获取 COVID-19 疫苗
Int J Public Health. 2021 Dec 31;66:1604236. doi: 10.3389/ijph.2021.1604236. eCollection 2021.
8
Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries.实施疫苗伤害无过错赔偿计划的国家的经济和免疫安全监测特征。
Vaccine. 2019 Jul 18;37(31):4370-4375. doi: 10.1016/j.vaccine.2019.06.018. Epub 2019 Jun 15.
9
Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.预留 2019 冠状病毒病疫苗以实现全球可及：横断面分析。
BMJ. 2020 Dec 15;371:m4750. doi: 10.1136/bmj.m4750.
10
Risky business: COVAX and the financialization of global vaccine equity.高风险的生意：COVAX 与全球疫苗公平的金融化。
Global Health. 2021 Sep 20;17(1):112. doi: 10.1186/s12992-021-00763-8.
引用本文的文献
1
A review of China's compensation program for adverse reactions following immunization.中国预防接种不良反应补偿方案综述。
Front Public Health. 2023 Aug 7;11:1211976. doi: 10.3389/fpubh.2023.1211976. eCollection 2023.
2
Promote COVID-19 Vaccination for Older Adults in China.在中国推广老年人新冠疫苗接种。
China CDC Wkly. 2022 Sep 16;4(37):832-834. doi: 10.46234/ccdcw2022.173.
3
No-Fault Compensation and Anti-COVID-19 Compulsory Vaccination: The Italian Context in a Broad View.无过错赔偿与新冠强制疫苗接种：广义视角下的意大利情况
Vaccines (Basel). 2022 Apr 19;10(5):635. doi: 10.3390/vaccines10050635.
Zotero 插件